九福来

The Breakthrough of PMAS on AIDS Treatment, High Praise from Tanzania Side

  • Categories:News
  • Time of issue:1536916440000

The Breakthrough of PMAS on AIDS Treatment, High Praise from Tanzania Side

  • Categories:News
  • Time of issue:2018-09-14 17:14

  On September 12, 2018, Mr. IGOGO, Special Economic adviser of the President of Tanzania, visits the headquarters of JUFEEL International Group, and specially thanks Professor Zhang Rongxuan, the international patent holder of PMAS technology and the chairman of the board of JUFEEL International Group, bringing PMAS clinical report of AIDS treatment in a number of hospitals in Tanzania. The results of PMAS treatment on AIDS far exceeds the expectations of the Tanzanian side; this technological breakthrough has been well-received, and Tanzania side praises Professor Zhang Rongxuan for his outstanding contribution to the medical and health care industry in Tanzania.

  “PMAS super ZD is great! The treatment effect on AIDS far exceeds our expectations!” At the JUFEEL International Group, Mr. IGOGO, Special Adviser of the President of Tanzania, excitedly embraces Professor Zhang Rongxuan.

  Mr. IGOGO tells the reporter that he specially thanks Professor Zhang Rongxuan for his trip and brings the clinical medical report of 10 hospitals in Tanzania. The results of clinical studies shows: the patients use PMAS super ZD (twice per day, 40 ml per time); after 30 days, one patient has a HIV load of 0; and after 90 days, 7 patients have HIV load of 0; The CD4 of all people's immune system indicators has increased to varying degrees, far exceeding the results achieved by current hospital treatment programs. The Tanzanian side is very grateful to Professor Zhang Rongxuan for helping the Tanzanian people to solve these medical problems such as immune diseases and cancer, and the contribution to the medical and health care in Tanzania.

  According to the data, in May 2016, “PMAS” aloe polysaccharide oral liquid is approved by the Tanzanian TFDA Drug and Food Administration for registration of drugs (registration number: TAN16FF0276). The PMAS used in clinical trials is donated to the National Institute of Health Research (NIMR) of the Ministry of Health of Tanzania in 2017 by the JUFEEL International Group in Dar es Salaam, Tanzania, valued at $5.3 million. At that time, Mr. Lin Zhiyong, Chief Representative of the Economic and Commercial Affairs of the People's Republic of China in Tanzania, Dr. Yunusdi, President of the NIMR of the Ministry of Health of Tanzania, Dr. Mu Shaya, Vice President Dr. Ma Shazhen, and Assistant Director of the Traditional Medicine and Health Bureau of the Ministry of Health Muha Dr. Mai, the chief expert of the State Food and Drug Administration, Dr. Karuuba and other relevant people witness

  the donation ceremony.

  During the donation activity, JUFEEL International Group and NIMR sign a three-year cooperative medical research agreement. The research direction is to solve the problems of nephrology, oncology, and immune system deficiency, the result of research will be used for the development of medical and health care in Tanzania.

  In the same year, the donation of the "PMAS Aloe Oral Liquid" is successfully tested by the international PONY test and the world's leading inspection, identification, testing and certification organization - Switzerland SGS.

  The Tanzanian Ministry of Health, the Food and Drug Administration, the Institute of Pharmaceutical Sciences, and the Ministry of Industry and Trade distribute the PMAS super ZD to Ocean Road Cancer Institute (ORCI), Muhimbili National Hospital (MNH), Palesting Hospital Sinza, Temeke Referral, Hospital, Mwannanyamala Referral Hospital, Vijibweni Hospital, Chanika Health Centre, Bugando Medical Centre, Musoma Regional Hospital, Rao Hospital, a total of 10 hospitals, selecting 38 AIDS patients in 6 regions, conducting a 90-day clinical study. And now the results of treatment highlight a major breakthrough.

  Professor Zhang Rongxuan said: "Aloe originated in Africa, transferred to the Caribbean, and 'settled' in the United States. We introduced aloe from the United States to China in 1999; and now let Aloe return to its hometown and benefit the homeland, and solve the problem in Africa, including AIDS, immune system deficiency, tumors and increasingly prominent kidney diseases; it plays an exemplary role in the control and treatment of AIDS worldwide; besides, Africa is very suitable for large-scale cultivation of aloe vera. We can help with the development of aloe vera. It is of great practical significance to maximize the local resources in African countries and use wild plants to promote human health level.

  According to reports, in 2017, Zhang Rongxuan, who enjoys the reputation of“Father of Chinese Aloe Vera”, is invited to the United States to participate in the United Nations “2030 Stop AIDS Spread” charity event, and is welcomed by US President Trump at the Congressman’s celebration feast. Meet. The United Nations World AIDS Organization (WAOUN) presents Zhang Rongxuan with "World Outstanding AIDS Prevention and Treatment Award" and fully affirms his contribution to the AIDS public welfare undertaking.

  At the 20th International Conference on STD-AIDS AND INFECTIOUS DISEASES, which is co-founded by the Cancer Immunology and Therapeutics, The Journal of Geriatric Psychiatry and The Journal of Bacteriology and Infectious Diseases, Mr. Stuartton (the chairman of the conference) personally presents Professor Zhang Rongxuan with the honorary certificate jointly awarded by the world's three prestigious universities, the University of Oxford, the University of Strasbourg, France, and the University of California, and he has highly affirms the research results of the prevention and treatment of AIDS of Professor Zhang Rongxuan and his team.

Back to list